| # | Drug | Count |
|---|---|---|
| 0 | MYCOPHENOLATE MOFETIL | 26 |
| 1 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 26 |
| 2 | TACROLIMUS | 23 |
| 3 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 19 |
| 4 | TACROLIMUS OINTMENT 0.1% | 19 |
| 5 | ADALIMUMAB | 17 |
| 6 | CYCLOPHOSPHAMIDE | 17 |
| 7 | CYCLOPHOSPHAMIDE FOR INJECTION | 17 |
| 8 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 17 |
| 9 | CYCLOSPORINE | 15 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | VANCOMYCIN HYDROCHLORIDE | 12 | 0.0014 |
| 1 | GANCICLOVIR SODIUM | 11 | 0.0010 |
| 2 | INFLIXIMAB-AXXQ | 1 | 0.0009 |
| 3 | PROBENECID | 1 | 0.0008 |
| 4 | HYDRALAZINE HYDROCHLORIDE | 2 | 0.0007 |
| 5 | ADENOSINE | 1 | 0.0006 |
| 6 | KETOROLAC TROMETHAMINE | 3 | 0.0006 |
| 7 | BUSULFAN | 9 | 0.0006 |
| 8 | ANIFROLUMAB-FNIA | 1 | 0.0005 |
| 9 | CYCLOSERINE | 1 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Type I Interferon Receptor Antagonist [EPC] | 1 | 0.0005 |
| 1 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 11 | 0.0005 |
| 2 | Osmotic Diuretic [EPC] | 1 | 0.0002 |
| 3 | Glycopeptide Antibacterial [EPC] | 12 | 0.0002 |
| 4 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 1 | 0.0002 |
| 5 | Adenosine Receptor Agonist [EPC] | 1 | 0.0001 |
| 6 | Nucleoside Analog Antiviral [EPC] | 11 | 0.0001 |
| 7 | Calcineurin Inhibitor Immunosuppressant [EPC] | 15 | 0.0001 |
| 8 | Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 11 | 0.0001 |
| 9 | Antimetabolite Immunosuppressant [EPC] | 2 | 0.0001 |